What should the Airway Pressure Release Ventilation (APRV) settings be for a patient with Acute Respiratory Distress Syndrome (ARDS) and how should they be set?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

APRV Settings in ARDS: A Practical Guide

While major ARDS guidelines do not provide specific recommendations for APRV settings, the mode can be used as a rescue strategy for refractory hypoxemia when conventional lung-protective ventilation fails, with settings based on the "open lung" approach.

Critical Context

The Surviving Sepsis Campaign 1 and American Thoracic Society guidelines 2 do not include APRV in their recommendations. These guidelines strongly recommend conventional lung-protective ventilation with tidal volumes of 6 mL/kg predicted body weight and plateau pressures ≤30 cmH2O 1. APRV is notably absent from guideline-level evidence, positioning it as an alternative or rescue mode rather than first-line therapy.

When to Consider APRV

APRV is typically reserved for:

  • Severe ARDS with refractory hypoxemia despite optimized conventional ventilation
  • Failure of standard lung-protective strategies including higher PEEP, recruitment maneuvers, and prone positioning 1, 3
  • PaO2/FiO2 ratios <150 mmHg that persist despite guideline-recommended interventions

Important caveat: Before initiating APRV, ensure you have exhausted guideline-supported interventions including prone positioning (strong recommendation for PaO2/FiO2 <150) 1 and consider neuromuscular blockade for 48 hours 1.

APRV Parameter Settings

Based on available evidence 4, 5, 6, here is a practical approach:

Initial Settings:

P-high (High Pressure):

  • Set equal to the plateau pressure from conventional ventilation (typically 25-30 cmH2O)
  • Maximum should not exceed 30-35 cmH2O to maintain lung protection 4
  • This maintains alveolar recruitment throughout most of the respiratory cycle

T-high (Time at High Pressure):

  • Set between 4-6 seconds 4
  • This prolonged inflation time promotes alveolar recruitment and oxygenation
  • Allows unrestricted spontaneous breathing at the higher pressure level

P-low (Low Pressure):

  • Set at 0 cmH2O 4
  • This brief release allows CO2 elimination
  • The rapid drop creates the "release" phase

T-low (Release Time):

  • Set at 0.4-0.8 seconds 4, 5
  • Critical parameter: terminate release when expiratory flow decreases to 50-75% of peak expiratory flow
  • This prevents complete alveolar collapse and maintains recruitment
  • Monitor the expiratory flow waveform closely

Tidal Volume During Release:

  • Maximum allowed: 4-6 mL/kg predicted body weight 4
  • Measure the volume delivered during the release phase
  • If exceeding 6 mL/kg, increase P-low or decrease T-low

Monitoring and Adjustment

Oxygenation optimization:

  • Adjust P-high and T-high to improve oxygenation
  • Increasing P-high recruits more alveoli but risks barotrauma
  • Increasing T-high prolongs recruitment time

Ventilation optimization:

  • Adjust release frequency (by changing T-high) to manage CO2
  • Ensure adequate release volumes without excessive stretch

Hemodynamic monitoring:

  • High mean airway pressures can impair venous return
  • Monitor for hypotension and adjust vasopressor support as needed
  • Consider reducing P-high if hemodynamic compromise occurs

Weaning from APRV

When patient improves (FiO2 ≤0.4, improving compliance):

  1. Gradually reduce P-high to reach target of 10 cmH2O 4
  2. Gradually increase T-high to reach target of 10 seconds 4
  3. Transition criteria to CPAP: FiO2 ≤0.4, P-high ≤10 cmH2O, T-high ≥10 seconds 4
  4. Then follow standard weaning protocols per guidelines 1

Critical Pitfalls and Barriers

Major barriers to APRV use 4, 7:

  • Lack of standardized protocols (most common barrier - 77.9% of clinicians)
  • Insufficient training and education
  • Significant practice variability between centers
  • No mortality benefit proven in randomized trials

Safety concerns:

  • Risk of volutrauma if release volumes exceed lung-protective limits 5
  • Potential for increased work of breathing
  • Requires continuous monitoring of spontaneous breathing effort
  • Avoid in patients with high intracranial pressure or severe hemodynamic instability

Evidence Quality Assessment

The evidence for APRV is weak and inconsistent 8, 5, 9. One retrospective study showed improved oxygenation and trend toward lower mortality 6, but this lacks the rigor of randomized controlled trials. The 2017 expert opinion on ARDS respiratory support 3 does not recommend APRV as a standard intervention. Recent surveys reveal substantial knowledge gaps and practice variability among clinicians 4, 7.

Given the absence of guideline support and limited evidence, APRV should only be used by experienced clinicians in centers with established protocols, and only after conventional lung-protective strategies have failed. The priority remains adherence to proven interventions: low tidal volumes, plateau pressure limits, higher PEEP for moderate-severe ARDS, and prone positioning for severe cases 1, 2.

References

Related Questions

In a patient with severe acute respiratory distress syndrome on day 10 who has been kept supine, should I initiate an airway pressure release ventilation (APRV) trial with spontaneous breathing?
What should be the APRV (Airway Pressure Release Ventilation) settings on the ventilator for a 57‑year‑old female with ARDS, weight 50 kg, height 156 cm, and a plateau pressure of 27 cm H₂O?
What is the appropriate initial assessment and management for a child with acute respiratory distress?
What are the latest Berlin criteria for diagnosing acute respiratory distress syndrome (ARDS)?
For a pregnant woman who presented with acute respiratory distress, was appropriately treated and is now stable for discharge, which medication should be prescribed at discharge?
In a non‑pregnant adult presenting with hematuria, hypogastric pain, and flank pain, what is the appropriate diagnosis and treatment?
Is the use of boric acid safe during breastfeeding?
For acute bacterial tonsillitis in a patient without a penicillin allergy, which is the preferred oral therapy: clindamycin or amoxicillin‑clavulanate?
What are the drug interactions and management considerations when co‑administering fluconazole with a standard Helicobacter pylori eradication regimen (clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily, and a proton‑pump inhibitor twice daily)?
In a patient with lumbar MRI showing mild dextroscoliosis, Modic changes at the inferior L5 endplate, lower lumbar facet arthropathy, and disc bulges at L1‑2, L2‑3, L3‑4 (2 mm), L4‑5 (mild anterior thecal sac effacement), and L5‑S1 (4 mm) causing minimal anterior thecal sac effacement, how should the patient be positioned and protected during surgery to avoid hip positioning that could push the posterior disc bulges at L4‑5 and L5‑S1 further toward the thecal sac?
Is there any renal benefit of mirtazapine in chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.